Seronegative Catastrophic Antiphospholipid Syndrome: A Case Report of a Deadly Diagnosis

Catastrophic antiphospholipid syndrome (CAPS) is a rare autoimmune condition that causes diffuse hypercoagulability affecting multiple organ systems. Typically, CAPS is diagnosed via serological workup, clinical findings, or histopathological findings. However, patients with clinical features of CAPS have been found to be seronegative. This case report aims to inform clinicians of the growing array of CAPS serological markers and the need for further research into these markers to assess clinical viability. Here, we present a case of a 51-year-old female who presented with multi-system thrombosis and was diagnosed with seronegative CAPS (SN-CAPS). Given the significant mortality rate associated with CAPS, it is imperative that an early diagnosis is established, and treatment is initiated. Thus, continued serological research for CAPS is required to aid in this effort.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-10-03
DOI
https://doi.org/10.7759/cureus.70785
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Seronegative Catastrophic Antiphospholipid Syndrome: A Case Report of a Deadly Diagnosis

Parth Desai, Sanjay Lamsal, Oshin Rai, Nadim Qadir et al.
Cureus
Systemic Lupus Erythematosus Research
article

Seronegative Catastrophic Antiphospholipid Syndrome: A Case Report of a Deadly Diagnosis

Parth Desai, Sanjay Lamsal, Oshin Rai, Nadim Qadir, Pramod Reddy, Michael Cargill, Hamza Choudhry
article en

Abstract

Catastrophic antiphospholipid syndrome (CAPS) is a rare autoimmune condition that causes diffuse hypercoagulability affecting multiple organ systems. Typically, CAPS is diagnosed via serological workup, clinical findings, or histopathological findings. However, patients with clinical features of CAPS have been found to be seronegative. This case report aims to inform clinicians of the growing array of CAPS serological markers and the need for further research into these markers to assess clinical viability. Here, we present a case of a 51-year-old female who presented with multi-system thrombosis and was diagnosed with seronegative CAPS (SN-CAPS). Given the significant mortality rate associated with CAPS, it is imperative that an early diagnosis is established, and treatment is initiated. Thus, continued serological research for CAPS is required to aid in this effort.

CureusVol. 16(10)
Jacksonville University (US)
Openalex Percentile: Top 70%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.